Red
Brand Name(s):Arixtra
Indication:Acute DVT and PE, and prevention of VTE in high-risk patients. Acute symptomatic spontaneous superficial vein thrombosis of the lower limbs without concomitant deep vein thrombosis.
Rationale:1,2
Considered:Feb-07
Review Date:Mar-22
Comments:
NICE Clinical Guideline 92
Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital January 2010